The largest database of trusted experimental protocols

Elecsys 1010 2010 system

Manufactured by Roche
Sourced in Germany

The Elecsys 1010/2010 System is an automated immunoassay analyzer developed by Roche. It is designed for the quantitative determination of various analytes in human body fluids. The system utilizes electrochemiluminescence technology to perform immunoassay tests.

Automatically generated - may contain errors

2 protocols using elecsys 1010 2010 system

1

Serum Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following an overnight fast (8 hours), blood samples were collected. Venous blood was drawn and sera were then collected after centrifugation at 3000×g for 15 min after coagulation. Serum was stored in the refrigerator at 4°C in aliquots until analysis. All laboratory variables were measured by a central laboratory that undergoes regular internal and external quality audits. A fully automatic biochemical analyzer (Roche, Mannheim, Germany) was used to determine the serum parameters. N-terminal pro-B type natriuretic peptide (NT-proBNP) was measured by using an immunoassay based on electrochemiluminescence with the Elecsys 1010/2010 System (Roche Diagnostics, Mannheim, Germany).
+ Open protocol
+ Expand
2

Hemodynamic Measurements and WHO-FC in IPAH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients with IPAH underwent right heart catheterization 1 week after blood collection, and baseline hemodynamic indicators such as heart rate, systolic blood pressure, diastolic blood pressure, mean right atrial pressure, mean pulmonary artery pressure, pulmonary vascular resistance, and cardiac output were measured as described previously (Radu et al., 2010 (link)). No changes in patient clinical status were observed between blood sampling and right heart catheterization. Cubic CO was measured by cold isotonic sodium chloride solution thermal dilution method. PVR was calculated by dividing the difference between mPAP and pulmonary artery wedge pressure by CO. The WHO-FC was determined according to the European PAH guidelines (Galiè et al., 2015 (link)). Electrochemiluminescence immunoassays based on the Elecsys 1010/2010 system (Roche Diagnostics GmbH, Mannheim, Germany) were used to quantify total plasma FSH concentration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!